ClearPoint Neuro (CLPT) Return on Capital Employed (2012 - 2026)
ClearPoint Neuro recorded quarterly Return on Capital Employed of 30.75% in Q1 2026, up 13.09% quarter-over-quarter from 35.39% in Q4 2025, and up 4734.0% year-over-year from 0.64% in Q1 2025.
ClearPoint Neuro's Return on Capital Employed history runs 14 years deep, the most recent figure standing at 30.75% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 4734.0% year-over-year to 30.75%; the TTM figure through Mar 2026 stood at 30.75% (up 4734.0% YoY), while the FY2025 annual figure was 41.88%, up 2267.0% from the prior year.
- Return on Capital Employed came in at 30.75% for Q1 2026 at ClearPoint Neuro, up from 35.39% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 25.22% in Q1 2022 to a low of 78.09% in Q1 2025.
- A 5-year average of 46.91% and a median of 48.43% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed plunged 2989 bps in 2023 and jumped 4734 bps in 2026, its largest moves.
- ClearPoint Neuro's Return on Capital Employed stood at 32.78% in 2022, then sank by 91 bps to 62.67% in 2023, then fell by 7 bps to 67.26% in 2024, then jumped by 47 bps to 35.39% in 2025, then advanced by 13 bps to 30.75% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 30.75%, 35.39%, and 42.49% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -30.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.75% |
| Dec 31, 2025 | -35.39% |
| Sep 30, 2025 | -42.49% |
| Jun 30, 2025 | -57.94% |
| Mar 31, 2025 | -78.09% |
| Dec 31, 2024 | -67.26% |
| Sep 30, 2024 | -48.43% |
| Jun 30, 2024 | -50.93% |
| Mar 31, 2024 | -63.50% |
| Dec 31, 2023 | -62.67% |
| Sep 30, 2023 | -55.32% |
| Jun 30, 2023 | -49.38% |
| Mar 31, 2023 | -38.83% |
| Dec 31, 2022 | -32.78% |
| Sep 30, 2022 | -29.96% |
| Jun 30, 2022 | -28.55% |
| Mar 31, 2022 | -25.22% |
| Dec 31, 2021 | -21.44% |
| Sep 30, 2021 | -17.68% |
| Jun 30, 2021 | -13.24% |
| Mar 31, 2021 | -14.75% |
| Dec 31, 2020 | -27.67% |
| Sep 30, 2020 | -28.70% |
| Jun 30, 2020 | -25.72% |
| Mar 31, 2020 | -34.23% |
| Dec 31, 2019 | -52.06% |
| Sep 30, 2019 | -45.91% |
| Jun 30, 2019 | -61.84% |
| Mar 31, 2019 | -87.68% |
| Dec 31, 2018 | -82.00% |
| Sep 30, 2018 | -73.68% |
| Jun 30, 2018 | -113.40% |
| Mar 31, 2018 | -95.38% |
| Sep 30, 2016 | -175.83% |
| Jun 30, 2016 | -230.72% |
| Mar 31, 2016 | -161.25% |
| Sep 30, 2015 | 1,505.19% |
| Jun 30, 2015 | 6,239.54% |
| Mar 31, 2015 | -162.37% |
| Dec 31, 2014 | -105.86% |
| Sep 30, 2014 | -323.93% |
| Jun 30, 2014 | -87.70% |
| Mar 31, 2014 | -101.83% |
| Dec 31, 2013 | 536.26% |
| Sep 30, 2013 | -149.35% |
| Jun 30, 2013 | -73.18% |
| Mar 31, 2013 | -113.05% |
| Dec 31, 2012 | -1,459.74% |
| Sep 30, 2012 | 106.34% |
| Jun 30, 2012 | 105.08% |
| Mar 31, 2012 | 87.40% |